跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Iobrix 300
Approved
STANDARD
Iobrix 300
Taejoon Pharm. Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
41f0c08f61c9b546
Company
Taejoon Pharm. Co., Ltd.
Type
Standard
Approval Details
Approval Id
41f0c08f61c9b546
Drug Approval Philippines Name
Iobrix 300
Product Name
Iobrix 300
Registration Number
DR-XY41711
Brand Name
Iobrix 300
Generic Name
Iohexol
Dosage Form
Solution For (Iv) Injection
Dosage Strength
647mg/mL (Equivalent to 300mg Iodine)
Manufacturer
Taejoon Pharm. Co., Ltd.
Importer
Patient Care Corportation
Distributor
Patient Care Corportation
Company Detail Path
/organization/taejoon-pharm-co-ltd
Issuance Date
17 January 2025
Expiry Date
21 February 2030
Pharmacologic Category
Radiocontrast Media (Non-Ionic)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
41f0c08f61c9b546
Type
Standard
Back to Philippines FDA Approvals
Iobrix 300 - Philippines FDA Drug Approval Details